Pearl Pathways is excited to announce the addition of Mary Anne Gfell to the team as a Clinical Research Advisor. Bringing over 15 years of experience in clinical research and quality compliance, Gfell is a key addition to the Pearl Pathways team. Prior to joining...
The 21st Century Cares Act was passed with an overwhelming majority on July 10th, 2015. This bill would increase the funding for both the NIH and FDA and instate a new framework for evaluating patience’s experience with drugs risks and benefits. Not only will the bill...
A recent study by Frost & Sullivan shows that the clinical research market for contract research organizations (CROs) in Latin America are projected to grow at a rate of 7.1% for the next four years, as it predicts that the larger CROs will take the greatest...
Clinical trial sponsors and contract research organizations (CRO) are working together to find a balance between the level of micromanagement and the quality of trials. Outsourcing-Pharma.com’s Zachary Brennan reports that recent studies found that only 41% of...
IMARC Research, a contract research organization (CRO) recently published a list of the “Top Five FDA Warning Letter Findings for Clinical Investigators.” Warning letters are issued when FDA finds objectionable conditions upon inspection. IMARC’s top 5 noted...
